{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:01Z","timestamp":1791286921623,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-024-00519-5","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:05:48Z","timestamp":1725609948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Equol exerts anti-tumor effects on choriocarcinoma cells by promoting TRIM21-mediated ubiquitination of ANXA2"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiao-Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Xue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1148\/rg.2017160140","volume":"37","author":"AM Shaaban","year":"2017","unstructured":"Shaaban AM, Rezvani M, Haroun RR, et al. Gestational trophoblastic disease: clinical and imaging features. Radiograph: Rev Pub Radiol Soc North Am, Inc. 2017;37:681\u2013700.","journal-title":"Radiograph: Rev Pub Radiol Soc North Am, Inc"},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","volume":"137","author":"JT Soper","year":"2021","unstructured":"Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol. 2021;137:355\u201370.","journal-title":"Obstet Gynecol"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.6004\/jnccn.2019.0053","volume":"17","author":"NR Abu-Rustum","year":"2019","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, et al. Gestational trophoblastic neoplasia, version 2.2019, NCCN Clinical practice guidelines in oncology. J Natl Compr Cancer Netw: JNCCN. 2019;17:1374\u201391.","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.bmc.2003.11.035","volume":"12","author":"RS Muthyala","year":"2004","unstructured":"Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004;12:1559\u201367.","journal-title":"Bioorg Med Chem"},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/ajcn\/40.3.569","volume":"40","author":"KD Setchell","year":"1984","unstructured":"Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984;40:569\u201378.","journal-title":"Am J Clin Nutr"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/cas.12948","volume":"107","author":"M Itsumi","year":"2016","unstructured":"Itsumi M, Shiota M, Takeuchi A, et al. Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2. Cancer Sci. 2016;107:1022\u20138.","journal-title":"Cancer Sci"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/molecules26041105","volume":"26","author":"R Hod","year":"2021","unstructured":"Hod R, Maniam S, Mohd Nor NH. A systematic review of the effects of equol (soy metabolite) on breast cancer. Molecules (Basel, Switzerland). 2021;26:1105.","journal-title":"Molecules (Basel, Switzerland)"},{"key":"519_CR8","doi-asserted-by":"publisher","first-page":"1369s","DOI":"10.3945\/jn.109.118323","volume":"140","author":"JW Lampe","year":"2010","unstructured":"Lampe JW. Emerging research on equol and cancer. J Nutr. 2010;140:1369s\u201372s.","journal-title":"J Nutr"},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"108910","DOI":"10.1016\/j.jnutbio.2021.108910","volume":"100","author":"S Yamashita","year":"2022","unstructured":"Yamashita S, Lin I, Oka C, et al. Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP associated domain containing 5-dependent and an estrogen receptor-independent manner. J Nutr Biochem. 2022;100:108910.","journal-title":"J Nutr Biochem"},{"key":"519_CR10","first-page":"4985","volume":"34","author":"EY Kim","year":"2014","unstructured":"Kim EY, Shin JY, Park YJ, Kim AK. Equol induces mitochondria-mediated apoptosis of human cervical cancer cells. Anticancer Res. 2014;34:4985\u201392.","journal-title":"Anticancer Res"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.14348\/molcells.2016.0162","volume":"39","author":"Z Yang","year":"2016","unstructured":"Yang Z, Zhao Y, Yao Y, et al. Equol induces mitochondria-dependent apoptosis in human gastric cancer cells via the sustained activation of ERK1\/2 pathway. Mol Cells. 2016;39:742\u20139.","journal-title":"Mol Cells"},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"738473","DOI":"10.3389\/fimmu.2021.738473","volume":"12","author":"EL Jones","year":"2021","unstructured":"Jones EL, Laidlaw SM, Dustin LB. TRIM21\/Ro52: roles in innate immunity and autoimmune disease. Front Immunol. 2021;12:738473.","journal-title":"Front Immunol"},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/onc.2010.462","volume":"30","author":"Y Chu","year":"2011","unstructured":"Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30:1108\u201316.","journal-title":"Oncogene"},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","volume":"167","author":"E Ben-Chetrit","year":"1988","unstructured":"Ben-Chetrit E, Chan EK, Sullivan KF, Tan EM. A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle. J Exp Med. 1988;167:1560\u201371.","journal-title":"J Exp Med"},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/ijc.34869","volume":"154","author":"GH Kara-Ali","year":"2024","unstructured":"Kara-Ali GH, Cano L, Dion S, et al. Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation. Int J Cancer. 2024;154:1999\u20132013.","journal-title":"Int J Cancer"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02583-z","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen X, Yong H, Chen M, et al. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. J Exp Clin Cancer Res: CR. 2023;42:34.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shen Y, Zhang Q, et al. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer. Cell Death Dis. 2023;14:850.","journal-title":"Cell Death Dis"},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1039\/c1ob05112a","volume":"9","author":"AM Fleming","year":"2011","unstructured":"Fleming AM, Muller JG, Ji I, Burrows CJ. Characterization of 2\u2019-deoxyguanosine oxidation products observed in the Fenton-like system Cu(II)\/H2O2\/reductant in nucleoside and oligodeoxynucleotide contexts. Org Biomol Chem. 2011;9:3338\u201348.","journal-title":"Org Biomol Chem"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jvh.12410","volume":"22","author":"M Ayd\u0131n","year":"2015","unstructured":"Ayd\u0131n M, Ayd\u0131n S, Bacanl\u0131 M, Ba\u015faran N. Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Bal\u0131kesir. Turk J Viral Hepat. 2015;22:926\u201335.","journal-title":"Turk J Viral Hepat"},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cac2.12386","volume":"43","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Q, Yang J, et al. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination\/degradation of STAT1 in a GTP binding-dependent modality. Cancer Commun (Lond, Engl). 2023;43:123\u201349.","journal-title":"Cancer Commun (Lond, Engl)"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules (Basel, Switzerland). 2015;20:13384\u2013421.","journal-title":"Molecules (Basel, Switzerland)"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-17-1915","volume":"77","author":"X Yan","year":"2017","unstructured":"Yan X, Zhang D, Wu W, et al. Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a. Can Res. 2017;77:6704\u201316.","journal-title":"Can Res"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/09513590500282273","volume":"21","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Briese V, Richter DU, et al. Effects of phytoestrogens genistein and daidzein on production of human chorionic gonadotropin in term trophoblast cells in vitro. Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol. 2005;21:180\u20134.","journal-title":"Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol"},{"key":"519_CR25","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3892\/or.2017.5928","volume":"38","author":"W Zheng","year":"2017","unstructured":"Zheng W, Sun R, Yang L, et al. Daidzein inhibits choriocarcinoma proliferation by arresting cell cycle at G1 phase through suppressing ERK pathway in vitro and in vivo. Oncol Rep. 2017;38:2518\u201324.","journal-title":"Oncol Rep"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"10385","DOI":"10.3748\/wjg.v21.i36.10385","volume":"21","author":"ZP Yang","year":"2015","unstructured":"Yang ZP, Zhao Y, Huang F, et al. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway. World J Gastroenterol. 2015;21:10385\u201399.","journal-title":"World J Gastroenterol"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"108064","DOI":"10.1016\/j.abb.2019.108064","volume":"672","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ren L, Yu M, et al. S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7 cells via regulating miR-10a-5p and PI3K\/AKT pathway. Arch Biochem Biophys. 2019;672:108064.","journal-title":"Arch Biochem Biophys"},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res: CR. 2011;30:87.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","volume":"73","author":"SL Fink","year":"2005","unstructured":"Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73:1907\u201316.","journal-title":"Infect Immun"},{"key":"519_CR31","first-page":"6093","volume":"17","author":"W Zheng","year":"2018","unstructured":"Zheng W, Liu T, Sun R, et al. Daidzein induces choriocarcinoma cell apoptosis in a dose-dependent manner via the mitochondrial apoptotic pathway. Mol Med Rep. 2018;17:6093\u20139.","journal-title":"Mol Med Rep"},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/ijms14010158","volume":"14","author":"YL Lo","year":"2012","unstructured":"Lo YL. A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells. Int J Mol Sci. 2012;14:158\u201376.","journal-title":"Int J Mol Sci"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41523-023-00588-1","volume":"9","author":"N Huang","year":"2023","unstructured":"Huang N, Li P, Sun X, et al. TRIM21 mediates the synergistic effect of Olaparib and Sorafenib by degrading BRCA1 through ubiquitination in TNBC. NPJ breast cancer. 2023;9:85.","journal-title":"NPJ breast cancer"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chembiol.2023.05.009","volume":"30","author":"YX Liu","year":"2023","unstructured":"Liu YX, Wan S, Yang XQ, et al. TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell Chem Biol. 2023;30:709-725.e706.","journal-title":"Cell Chem Biol"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13046-022-02526-8","volume":"41","author":"Z Gao","year":"2022","unstructured":"Gao Z, Xu J, Fan Y, et al. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells. J Exp Clin Cancer Res: CR. 2022;41:323.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"216733","DOI":"10.1016\/j.canlet.2024.216733","volume":"587","author":"J Yuan","year":"2024","unstructured":"Yuan J, Zhu Z, Zhang P, et al. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Cancer Lett. 2024;587:216733.","journal-title":"Cancer Lett"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/bjd.19057","volume":"184","author":"L Yang","year":"2021","unstructured":"Yang L, Zhang T, Zhang C, et al. Upregulated E3 ligase tripartite motif-containing protein 21 in psoriatic epidermis ubiquitylates nuclear factor-\u03baB p65 subunit and promotes inflammation in keratinocytes. Br J Dermatol. 2021;184:111\u201322.","journal-title":"Br J Dermatol"},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2024.2305063","volume":"20","author":"M Koh","year":"2024","unstructured":"Koh M, Lim H, Jin H, et al. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells. Autophagy. 2024;20:659\u201374.","journal-title":"Autophagy"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13046-018-0851-y","volume":"37","author":"S Ma","year":"2018","unstructured":"Ma S, Lu CC, Yang LY, et al. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. J Exp Clin Cancer Res: CR. 2018;37:183.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00018-023-05049-3","volume":"81","author":"C Gounou","year":"2023","unstructured":"Gounou C, Rouyer L, Siegfried G, et al. Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. Cell Mol Life Sci: CMLS. 2023;81:7.","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"11285","DOI":"10.1038\/s41598-018-29703-0","volume":"8","author":"MR Rocha","year":"2018","unstructured":"Rocha MR, Barcellos-de-Souza P, Sousa-Squiavinato ACM, et al. Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-\u00df induced epithelial mesenchymal transition via Src\/ANXA2\/STAT3. Sci Rep. 2018;8:11285.","journal-title":"Sci Rep"},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422\u20136.","journal-title":"Nature"},{"key":"519_CR43","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-17-3107","volume":"78","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zhou Y, Rychahou P, et al. Deptor is a novel target of Wnt\/\u03b2-catenin\/c-Myc and contributes to colorectal cancer cell growth. Can Res. 2018;78:3163\u201375.","journal-title":"Can Res"},{"key":"519_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/abbs\/gmz027","volume":"51","author":"J Wu","year":"2019","unstructured":"Wu J, Feng X, Du Y, et al. \u03b2-catenin\/LIN28B promotes the proliferation of human choriocarcinoma cells via Let-7a repression. Acta Biochim Biophys Sin. 2019;51:455\u201362.","journal-title":"Acta Biochim Biophys Sin"},{"key":"519_CR45","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.7150\/thno.37892","volume":"9","author":"T Tang","year":"2019","unstructured":"Tang T, Guo C, Xia T, et al. LncCCAT1 promotes breast cancer stem cell function through activating WNT\/\u03b2-catenin signaling. Theranostics. 2019;9:7384\u2013402.","journal-title":"Theranostics"},{"key":"519_CR46","first-page":"688","volume":"83","author":"MG Paunovi\u0107","year":"2022","unstructured":"Paunovi\u0107 MG, Mati\u0107 MM, Obradovi\u0107 AD, et al. Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines. Drug Dev Res. 2022;83:688\u201398.","journal-title":"Drug Dev Res"},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"1119274","DOI":"10.3389\/fnut.2023.1119274","volume":"10","author":"CA Gano","year":"2023","unstructured":"Gano CA, Fatima S, Failes TW, et al. Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines. Front Nutr. 2023;10:1119274.","journal-title":"Front Nutr"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00519-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:11:39Z","timestamp":1725613899000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00519-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00519-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving human samples and animals were conducted with the approval of the Ethics Committee of Shengjing Hospital of China Medical University for Ethical Review (Human study No. 2023PS012K; Animal study No. 2023PS011K). The informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}